Trevi Therapeutics (TRVI) did not pay dividends over the past year.

Trevi Therapeutics (TRVI) is currently trading at $14.12 with a P/E ratio of -43.27. This represents a -2,027% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 42.91%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

You can buy Trevi Therapeutics (TRVI) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol TRVI and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

Over the past month, Trevi Therapeutics (TRVI) has returned -16.57% — 42.91% over the past year, and 1,025.10% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Trevi Therapeutics (TRVI) today at the current price of $14.12 your total investment would be $1,412.00.

Based on historical performance, the investment would have grown to approximately:

• $2,017.89 after 1 year
• $15,886.41 after 5 years
• $1,412.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.